Exercise, GLP-1 receptor agonist, or combined approach explored in year-long study

Researchers compare the extent of weight loss after one-year termination of active intervention with GLP-1 receptor agonist, exercise, or combination.

To rebuild trust in public health: Better communication, fewer mandates, and small wins

It’s no surprise in today’s corrosive political environment that trust in government is near an all-time low. That’s a big problem. Communities with more trust

April 11, 2024

Phosphoproteomic profiling reveals the complex interplay of immune cells in tumors

Researchers from the Icahn School of Medicine at Mount Sinai, in collaboration with the Clinical Proteomic Tumor Analysis Consortium of the National Institutes of Health,

February 14, 2024

A new lobby shop looks to remind Congress about NIH’s translational research arm

WASHINGTON — Christopher Austin was the first director of a then-tiny National Institutes of Health department with an opaque name, the National Center for Advancing

July 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.